Literature DB >> 9286563

Report of the Japanese Central Bone Marrow Data Center.

H Tanaka1, T Akaza, T Juji.   

Abstract

The Japan Marrow Donor Program started to recruit donors at the beginning of 1992 with the financial support of the Japanese government, and the first unrelated bone marrow transplantation arranged through this program was performed in 1993. Since 1992, about 82,000 donors and 4,400 patients have been registered. At least one HLA-identical donor has been found for 60% of the patients in the first search after the patients register with the JMDP, and as of the end of September 1996, 880 patients had received bone marrow transplants from unrelated donors. The results of 19.7% of registered patients having received bone marrow transplants and 1.1% of registered donors having donated far exceed our forecasts. This is attributed to the high frequency of several haplotypes in the Japanese. However, no HLA-identical donors have been found for approximately 800 registered patients so far. Thus, it is still necessary to increase the number of donors registered with the JMDP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9286563

Source DB:  PubMed          Journal:  Clin Transpl        ISSN: 0890-9016


  15 in total

1.  Identification of CTL epitopes in hepatitis C virus by a genome-wide computational scanning and a rational design of peptide vaccine.

Authors:  Toshie Mashiba; Keiko Udaka; Yasuko Hirachi; Yoichi Hiasa; Tomoya Miyakawa; Yoko Satta; Tsutomu Osoda; Sayo Kataoka; Michinori Kohara; Morikazu Onji
Journal:  Immunogenetics       Date:  2007-01-16       Impact factor: 2.846

Review 2.  Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.

Authors:  Gergely Bodis; Victoria Toth; Andreas Schwarting
Journal:  Rheumatol Ther       Date:  2018-03-07

3.  High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population.

Authors:  Yoshiki Itoh; Nobuhisa Mizuki; Tsuyako Shimada; Fumihiro Azuma; Mitsuo Itakura; Koichi Kashiwase; Eri Kikkawa; Jerzy K Kulski; Masahiro Satake; Hidetoshi Inoko
Journal:  Immunogenetics       Date:  2005-11-08       Impact factor: 2.846

4.  Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus.

Authors:  Haruki Komatsu; Ayano Inui; Tsuyoshi Sogo; Eitaro Hiejima; Akihiko Tateno; Paul Klenerman; Tomoo Fujisawa
Journal:  BMC Infect Dis       Date:  2010-04-28       Impact factor: 3.090

5.  Familial clustering and genetic background of primary biliary cirrhosis in Japan.

Authors:  Masatoshi Yanagisawa; Hitoshi Takagi; Hitomi Takahashi; Masahiro Uehara; Toshiyuki Otsuka; Kazuhisa Yuasa; Kenichi Hosonuma; Masatomo Mori
Journal:  Dig Dis Sci       Date:  2009-12-11       Impact factor: 3.199

Review 6.  Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.

Authors:  Ratchadaporn Somkrua; Elizabeth E Eickman; Surasak Saokaew; Manupat Lohitnavy; Nathorn Chaiyakunapruk
Journal:  BMC Med Genet       Date:  2011-09-09       Impact factor: 2.103

7.  Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses.

Authors:  Haruki Komatsu; Ayano Inui; Tsuyoshi Sogo; Tomoo Fujisawa; Hironori Nagasaka; Shigeaki Nonoyama; Sophie Sierro; John Northfield; Michaela Lucas; Anita Vargas; Paul Klenerman
Journal:  Immun Ageing       Date:  2006-12-08       Impact factor: 6.400

8.  Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan.

Authors:  Tomoko Kurita; Tomomi Kitaichi; Takako Nagao; Toshiyuki Miura; Yoshifumi Kitazono
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-03-03       Impact factor: 2.890

9.  Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.

Authors:  Keiko Sakai; Takayuki Chikata; Zabrina L Brumme; Chanson J Brumme; Hiroyuki Gatanaga; Hiroyuki Gatanag; Shinichi Oka; Masafumi Takiguchi
Journal:  Retrovirology       Date:  2015-11-19       Impact factor: 4.602

10.  Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan.

Authors:  Tomoko Kurita; Tomomi Kitaichi; Takako Nagao; Toshiyuki Miura; Yoshifumi Kitazono
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-03-03       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.